Trials / Unknown
UnknownNCT00491270
Bacterial Vaginosis Screening and Treatment to Reduce Infective Complications, Abortion and Preterm Delivery
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Western Galilee Hospital-Nahariya · Other Government
- Sex
- Female
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
To determine whether screening of pregnant women with history of previous preterm delivery or with premature contractions for bacterial vaginosis using VS-SENSE, and treatment of positive women will reduce the risk of spontaneous preterm birth.
Detailed description
This is an open-label, comparative, and prospective study. Pregnant women, pregnancy week 26 to 36+6, between the ages 18-45, who were hospitalized in the high risk department, with history of previous preterm delivery and/or with premature contractions. Patient with premature ruptured membrane will be excluded. In the hospital pregnant women with history of previous preterm delivery or with premature contractions, (participants) will be examined by speculum with no lubricant, The clinician will use the VS-SENSE to sample vaginal secretions and will immediately observe and record the color obtained.Should the VS-SENSE produce positive results the physician will consider giving clindamycin treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | VS Sense | An applicator to diagnose pH increase above 5.2 |
Timeline
- Start date
- 2011-01-01
- Primary completion
- 2012-01-01
- Completion
- 2013-08-01
- First posted
- 2007-06-26
- Last updated
- 2011-05-25
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT00491270. Inclusion in this directory is not an endorsement.